“◐절대적인◑여의나루오피『 YEOTOP1.COM 』 여탑여의나루오피✴여의나루마사지ⅰ여의나루안마❘여의나루풀싸롱✒여의나루스파さ여의나루립카페”的搜索结果，显示 501-510 项，共有 12305 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   - No evidence of metastatic disease. Lymphadenopathy (defined as nodes measuring >1 cm in short axis) outside the surgical basin (i.e., para-aortic, peri ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The PD-1/PD-L1 cascade allows tumors to evade the immune system by suppressing T cell function within the TME. [5, 6] An ideal adoptive cellular therapy must ...

3. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood, and to establish the feasibility and safety of Dasatinib ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to design, develop and assess the performance characteristics of NGS assays using circulating tumor DNA for the ...

5. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

6. 神经科- 临床试验- 妙佑医疗国际

   Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...

7. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   Participants will be identified from the Olmsted County population age 18 or older. Inclusion criteria: 1. Adults age 18 years or older. 2. Olmsted County ...

8. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This study is a Phase III, randomised, open label, multi-centre study assessing the efficacy and safety of MEDI4736 versus Standard of Care in NSCLC ...

10. 神经科- 临床试验- 妙佑医疗国际

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...